Default: Bioanalysis

ISSN: 1757-6180

Journal Home

Journal Guideline

Bioanalysis Q2 Unclaimed

Future Science United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bioanalysis is a journal indexed in SJR in Medicine (miscellaneous) and Analytical Chemistry with an H index of 67. It has an SJR impact factor of 0,462 and it has a best quartile of Q2. It has an SJR impact factor of 0,462.

Bioanalysis focuses its scope in these topics and keywords: biological, msms, method, bioanalysis, quantitation, developmentstwostep, derivatization, doping, dried, drugs, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

Bioanalysis

0,462

SJR Impact factor

67

H Index

118

Total Docs (Last Year)

532

Total Docs (3 years)

3469

Total Refs

900

Total Cites (3 years)

469

Citable Docs (3 years)

1.55

Cites/Doc (2 years)

29.4

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


biological, msms, method, bioanalysis, quantitation, developmentstwostep, derivatization, doping, dried, drugs, ebf, emerging, endogenous, esims, evaluation, focus, future, glucagon, hatching, calibration, application, applications, analysisvolatile, assessment, athlete, bioanalytical, blood, business, anabolic, cards, carlo, chromatography, chromatographyimmunoaffinity, comparative,



Best articles by citations

Proteomics of drug-resistant cancer biomarkers

View more

The 5th Annual Shanghai Symposium on Clinical & Pharmaceutical Solutions through Analysis

View more

Recent advances in hydrophilic interaction chromatography for quantitative analysis of endogenous and pharmaceutical compounds in plasma samples

View more

Quantitative immunocapture MS: current status and challenges in drug discovery

View more

Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing

View more

Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis

View more

An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma

View more

Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity

View more

A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species

View more

7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing

View more

Hair: a complementary source of bioanalytical information in forensic toxicology

View more

Forensic and clinical toxicology

View more
SHOW MORE ARTICLES

Nonclinical immunogenicity risk assessment of therapeutic proteins

View more

Label-free MS imaging from drug discovery to preclinical development

View more

A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study

View more

Paper spray-MS for bioanalysis

View more

Recent advances in MS methods for nicotine and metabolite analysis in human matrices: clinical perspectives

View more

Determination of eniluracil and 5-fluorouracil in human plasma by LC-MS/MS

View more

Matrix effect and recovery terminology issues in regulated drug bioanalysis

View more

An optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples

View more

Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS

View more

Feedback from the European Bioanalysis Forum Workshop: taking tiered approach to the next level

View more

Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite

View more

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1 -small molecules by LCMS)

View more

FAQS